NCT07605429: BEACON - Phase III Clinical Study of Rugonersen in Angelman Syndrome.
- State
- Under way
- Phase
- Phase 3
- People
- 165 planned
- Started
- 23 Jun 2026
- Primary completion
- Mar 2029
- Arms
- rugonersen
- Results
- None posted
- 26 May 2026: Trial registered
- 23 Jun 2026: Trial started